French Insurtech Giant Alan Hits 5 Billion Valuation In Massive 100 Million Funding Round

The French insurtech startup Alan has taken a significant step forward in its growth journey, closing a massive €100 million funding round that values the company at an impressive €5 billion. The latest raise, backed by prominent investors including Index Ventures, Shopify’s Tobi Lütke, and World Cup winner Antoine Griezmann, underscores Alan’s commitment to expanding its reach and further developing its innovative insurance platform.

Founded in 2016 by CEO Jean-Charles Samuelian-Werve and CTO Charles Gorintin, the company aimed to revolutionize the French health insurance market with a modern, technology-driven approach. By becoming the first new independent health insurer in France in 30 years, Alan successfully navigated regulatory challenges and established itself as a pioneer in the industry.

Alan’s growth trajectory is marked by remarkable increases in annual recurring revenue (ARR), reaching €785 million in 2025, a staggering 53% year-over-year increase. The company is now targeting €1 billion in ARR by 2026, reflecting its confidence in capturing a significant share of the growing health insurance market.

The expansion plans are not limited to France, Alan’s largest market. The company has been actively exploring opportunities in Belgium, Spain, and Canada, securing notable partnerships with prominent clients such as HP and Volkswagen. In Canada, Alan received insurance licenses across all provinces and launched Alan Clinic, a mental health care service integrated directly into the app.

The company’s growth is also reflected in its member base, which now exceeds one million employees, freelancers, and retirees covered through its health insurance and wellness platform. This impressive figure underscores Alan’s ability to build a large and engaged community of customers, drawn to the company’s innovative approach to health insurance.

Despite its impressive growth, Alan still faces challenges in achieving full profitability. The company posted net losses of €61 million in 2023 and €56 million in 2024, although it has managed to halve its losses as a percentage of revenue over the past twelve months. To achieve operational break-even, Alan is investing heavily in product development, including AI-powered solutions.

The emphasis on AI is not surprising, given CEO Jean-Charles Samuelian-Werve’s affiliation with Mistral AI, the French AI champion. Alan itself holds a stake in Mistral and has been deploying AI across its platform for years, most notably through Mo, the AI health assistant launched for its 680,000-member base in late 2024.

The recent funding round is a testament to Alan’s growth potential and investor confidence. The involvement of prominent angel investors such as Tobi Lütke and Antoine Griezmann adds further credibility to the company’s ambitious plans. While neither Lütke nor Griezmann are typical insurtech investors, their involvement underscores Alan’s commitment to building a consumer brand that resonates with a wider audience.

The star-studded angel roster is a reflection of the cultural weight Alan has acquired in France, where the company has established itself as a leader in the health insurance market. With this funding round, Alan is well-positioned to continue its growth trajectory, expand its international presence, and further develop its innovative insurance platform.

As Alan looks to the future, it remains focused on investing in product development, including AI-powered solutions. By doing so, the company aims to enhance the user experience, improve operational efficiency, and drive growth. With a strong leadership team, a growing community of members, and a solid funding base, Alan is poised for continued success in the highly competitive health insurance market.

The company’s commitment to innovation, expansion, and sustainability will be crucial in driving its growth strategy forward. By leveraging its expertise in AI, building on its successful platform, and expanding into new markets, Alan is well-positioned to capture a significant share of the growing health insurance market.

Despite the challenges posed by the COVID-19 pandemic, Alan has demonstrated remarkable resilience and adaptability. The company’s ability to respond quickly to changing market conditions and regulatory requirements has enabled it to maintain its growth trajectory and establish itself as a leader in the French health insurance market.

Alan’s €5 billion valuation is a significant milestone that underscores the company’s growth potential and investor confidence. With this funding round, Alan is well-equipped to drive further innovation, expand its reach, and enhance the user experience. By building on its strong foundations and continuing to invest in product development, AI, and international expansion, Alan is poised for continued success in the highly competitive health insurance market.

Original Source

• Read the full article here